| BUDESONIDE; FORMOTEROL FUMARATE; GLYCOPYRROLATE | None | ||
| 0.16MG;0.0048MG;0.009MG |
Less Than $1000 mn
|
||
| None | None | ||
| None | None | ||
| None | None | ||
| BREZTRI AEROSPHERE is a combination of budesonide, an inhaled corticosteroid (ICS); glycopyrrolate, an anticholinergic; and formoterol fumarate, a long-acting beta2-adrenergic agonist (LABA), indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). | |||
|
Yes
| |||
| BREZTRI AEROSPHERE | Patent 1 | Patent 2 | Patent 3 | Patent 4 | Patent 5 | Patent 6 | Patent 7 | Patent 8 | Patent 9 |
|---|---|---|---|---|---|---|---|---|---|
| *** ********* | |||||||||
| ************, ******* *** ******* *** *********** ******** ** *** ** **** ****** ****** | ************, ******* *** **********-***** ******* *** *********** ******** ** ************** *** *** ** **** ****** ****** | ************ *** ********* ******** ** ****-****** β* ********** ******** ******** *** ********** ******* *** ******* | ************, ******* *** ******* *** *********** ******** ** *** ** **** ****** ****** | ************, ******* *** ******* *** *********** ******** ** *** ** **** ****** ****** | ************ *** ********* ******** ** ****-****** ********** *********** *** ********** ******* *** ******* | ************ *** ********* ******** ** ****-****** ********** *********** ** ****-****** ** ********** ******** ******** *** ********** ******* *** ******* | **** ******** ******* *** ******* ******* | **** ******** ******* *** ******* ******* |
Download ParaIV Report
| Drug Name | Generic Name | Dosage | Route of Administration | Probable FTF | Known Para IV Filers | Other ANDA Developers |
|---|